Home / SLC16A6 Knockout Cell Lines

SLC16A6 Knockout Cell Lines

Gene: SLC16A6

Official Full Name: solute carrier family 16 member 6provided by HGNC

Gene Summary: Predicted to enable monocarboxylic acid transmembrane transporter activity. Predicted to be involved in carboxylic acid transmembrane transport. Predicted to be located in basolateral plasma membrane. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO33576 SLC16A6 Knockout cell line (HeLa) Human SLC16A6 1:3~1:6 Negative Online Inquiry
KO33577 SLC16A6 Knockout cell line (HCT 116) Human SLC16A6 1:2~1:4 Negative Online Inquiry
KO33578 SLC16A6 Knockout cell line (HEK293) Human SLC16A6 1:3~1:6 Negative Online Inquiry

Background

SLC16A6 Gene Knockout Cell Lines represent a cutting-edge tool in molecular biology, specifically engineered to disrupt the expression of the SLC16A6 gene, which encodes a member of the monocarboxylate transporter (MCT) family. These cell lines facilitate the study of the gene's role in cellular metabolism, transport processes, and physiological functions by providing a controllable system to analyze the consequences of its absence on cellular physiology.

The SLC16A6 gene is primarily involved in the transport of lactate and other monocarboxylates across cell membranes, influencing metabolic pathways that are critical in various tissues, including the brain and skeletal muscle. By utilizing CRISPR-Cas9 technology, these knockout cell lines exhibit complete gene disruption, allowing researchers to investigate downstream effects, assess metabolic shifts, and explore therapeutic targets related to metabolic disorders, cancer biology, and neurology.

The importance of SLC16A6 Gene Knockout Cell Lines extends to both research and clinical applications. Researchers can leverage these models to gain insights into the transport mechanisms of monocarboxylate transporters and their implications in disease states. Moreover, the data gleaned from such studies can lead to innovations in developing targeted therapies that modulate MCT activity, particularly in metabolic syndromes and cancer.

What sets our SLC16A6 Gene Knockout Cell Lines apart is the precision of our gene-editing techniques, as well as the detailed characterization of the resulting cell lines, ensuring reliable reproducibility and validity of experimental outcomes. Compared to alternative models, our cell lines provide a more nuanced understanding of gene function and metabolic regulation, thanks to robust background knowledge and thorough validation that accompany each product.

By choosing SLC16A6 Gene Knockout Cell Lines, researchers and clinicians equip themselves with a powerful asset for advancing scientific knowledge and therapeutic development. Our company specializes in high-quality biological products and is committed to supporting the scientific community with solutions that enhance research quality and efficiency.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.